Regulatory press releases

 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.  Nanologica AB (publ) (”Nanologica” or the “Company”) today announces the outcome of the new shares issue with preferential rights for Nanologica’s existing shareholders (the

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. The Board of Directors of Nanologica AB (publ) (“Nanologica” or the Company”) announced on 23 August 2022 that the Board of Directors has resolved

Nanologica AB (publ) has taken an order for the company’s silica for preparative chromatography at a value of approximately MSEK 1.3. The order comes from Nanologica’s partner in China, Yunbo Technology (Beijing) Co. Ltd. In July 2019, Nanologica signed an agreement with Chinese Yunbo Technology for the supply of silica for preparative chromatography worth approximately MUSD 14 (currently equivalent to approximately MSEK 150), between 2021 and 2026. The order that has now been placed is